Targeting one type of immune cell with another slows cancer growth in preclinical studies
A new approach to cancer immunotherapy that uses one type of immune cell to kill another—rather than directly attacking the cancer—provokes a robust anti-tumor immune response that shrinks ovarian, lung, and pancreatic tumors ...
Oct 25, 2022
0
89
